Show results for
Refine by
Spinal Canal Articles & Analysis
2 news found
Centers for Disease Control noting inadequate effectiveness and inherent risks,6 and only 5% utilizing minimally invasive lumbar decompression treatment options which are now considered appropriate for earlier use.7 Other key findings (Click here for Executive Summary and here for Presentation) include: CLBP Has Significant Impact on Mobility and Long-term Negative Impact on Life More than ...
The device is located under the scalp, much like a cerebral spinal fluid (CSF) shunt. In March, the company received FDA breakthrough device designation for its ReFlow System Mini intended for the treatment of CSF disorders requiring shunting, such as hydrocephalus. ...